RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Efficacy and safety of imeglimin in type 2 diabetes: A systematic review and meta-analysis of randomized placebo-controlled trials.

Efficacy and safety of imeglimin in type 2 diabetes: A systematic review and meta-analysis of randomized placebo-controlled trials.

Add to Collection
2023 Feb Systematic Review and Meta Analysis AK Singh, A Singh, R Singh, A Misra - Diabetes & Metabolic Syndrome …, 2023 - Elsevier

Full Author : ['Singh, Awadhesh Kumar', 'Singh, Akriti', 'Singh, Ritu', 'Misra, Anoop']
Journal Title : Diabetes & metabolic syndrome
Chapter : Section3
Journal Year : 2023
Cited by : 1.0

BACKGROUND & AIMS: Imeglimin is a novel new oral compound recently approved for treating type 2 diabetes (T2D) in India. We conducted a systematic review and meta-analysis to evaluate the efficacy of imeglimin in people with T2D in the approved dose of 10..... Read More

Keywords : ["randomized placebocontrolle trial", "type diabetes", "systematic review", "safety", "metaanalysis", "imeglimin", "efficacy"]
PubMed Link : https://www.sciencedirect.com/science/article/pii/S1871402123000061
Google Scholar Link : https://scholar.google.com/scholar?cites=8980541935904600615&as_sdt=2005&sciodt=0,5&hl=en&num=20